Lawson Wilkins Pediatric Endocrine Society

Policy Statements Seperator

Member Login Seperator

Guidelines, Consensus Statements and Reviews
Seperator

These statements are provided by LWPES for reference and use by members. They represent statements sponsored by LWPES that the Society either initiated or was actively involved in developing.

Changes in Recombinant Human Growth Hormone (rhGH) Prescribing Information (Updated 2008)

Changes in Recombinant Human Growth Hormone (rhGH) Prescribing Information (Updated 2008) (pdf, 147KB)

Increasing Minority Participation in Clinical Research ( 2007)

Increasing Minority Participation in Clinical Research

Adrenal Insufficiency ( 2007)

Adrenal Insufficiency: Still a Cause of Morbidity and Death in Childhood (pdf, 285KB)

Childhood Obesity, 2005

Childhood Obesity (pdf, 161KB)

Diabetic Ketoacidosis (2004)

Consensus Statement on Diabetic Ketoacidosis in Children and Adolescents (pdf, 268KB)

Growth Hormone in Children, 2003

Update of Guidelines for the Use of Growth Hormone in Children: The Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee (pdf, 129KB)

Growth Hormone Treatment and Neoplasia (2002)

Growth Hormone Treatment and Neoplasia-coincidence or consequence? (pdf, 46KB)

Insulin Infusion, 2006

Continuous Subcutaneous Insulin Infusion in Very Young Children With Type 1 Diabetes (pdf, 259KB)

Menstruation in Adolescent Females, 2004

Clinical Management of Menstruation in Adolescent Females With Developmental Delay (pdf, 69KB)

Pediatric Bone Disease, 2005

Bisphosphonate Treatment of Pediatric Bone Disease (pdf, 368KB)

Precocious Puberty in Girls (1999)

Reexamination of the Age for Defining When Puberty is Precocious in Girls in the United States (pdf, 321KB)